Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma

Conditions:   Soft Tissue Sarcoma;   Undifferentiated Pleomorphic Sarcoma;   Myxofibrosarcoma;   Leiomyosarcoma;   Liposarcoma;   Angiosarcoma;   Synovial Sarcoma;   Rhabdomyosarcoma;   Spindle Cell Sarcoma;   High Grade Sarcoma;   Bone Sarcoma;   Osteosarcoma;   Ewing Sarcoma of Bone Interventions:   Drug: Gemcitabine;   Drug: 9-ING-41;   Drug: Docetaxel Sponsors:   Brown University;   Actuate Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials